Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | SNCA | P37840 | 1/20 | 0.39 |
| ▸ | PLAAT3 | P53816 | 1/20 | 0.38 |
| ▸ | PLAAT5 | Q96KN8 | 1/20 | 0.38 |
| ▸ | PLAAT2 | Q9NWW9 | 1/20 | 0.38 |
| ▸ | PLAAT4 | Q9UL19 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15294939 | 0.86 | RAB9A (0.51) | GFERADORA2AADORA1NPC1RAB9A | |
| SCHEMBL42291 | 0.81 | SMN1; SMN2 (0.50) | NPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL13056574 | 0.80 | SMN1; SMN2 (0.48) | NPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL23308032 | 0.79 | SMN1; SMN2 (0.43) | NPC1RAB9ASMN1; SMN2GAAKDM4E | |
| SCHEMBL13056573 | 0.79 | MEN1 (0.40) | NPC1RAB9ASMN1; SMN2GAAMEN1 | |
| SCHEMBL18680081 | 0.78 | SMN1; SMN2 (0.43) | NPC1RAB9ASMN1; SMN2GAAKDM4E | |
| SCHEMBL13056575 | 0.78 | SMN1; SMN2 (0.47) | NPC1RAB9ASMN1; SMN2MEN1KMT2A | |
| SCHEMBL13056576 | 0.77 | SMN1; SMN2 (0.46) | NPC1RAB9ASMN1; SMN2GAAKDM4E | |
| SCHEMBL24012381 | 0.77 | KDM4E (0.66) | GFERSMN1; SMN2KDM4ELMNAMAPT | |
| SCHEMBL18685198 | 0.76 | SMN1; SMN2 (0.41) | NPC1RAB9ASMN1; SMN2GAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3764084-A1 | DIGITALLY ENHANCED MICROSCOPY FOR MULTIPLEXED HISTOLOGY | Ventana Medical Systems, Inc. (US) | 2021-01-13 | — | — | EP | disclosed |
| EP-3764083-A1 | DIGITALLY ENHANCED MICROSCOPY FOR MULTIPLEXED HISTOLOGY | Ventana Medical Systems, Inc. (US) | 2021-01-13 | — | — | EP | disclosed |
| EP-2972227-B1 | DIGITALLY ENHANCED MICROSCOPY FOR MULTIPLEXED HISTOLOGY | VENTANA MED SYST INC (US) | 2020-05-06 | — | — | EP | disclosed |
| US-10041950-B2 | Signaling conjugates and methods of use | VENTANA MEDICAL SYSTEMS, INC. (US) | 2018-08-07 | — | — | US | disclosed |
| EP-2831587-B1 | SIGNALING CONJUGATES AND METHODS OF USE | VENTANA MED SYST INC (US) | 2018-05-16 | — | — | EP | disclosed |
| US-20140267672-A1 | DIGITALLY ENHANCED MICROSCOPY FOR MULTIPLEXED HISTOLOGY | VENTANA MEDICAL SYSTEMS, INC. | 2014-09-18 | — | — | US | disclosed |
| US-20140267672-A1 | DIGITALLY ENHANCED MICROSCOPY FOR MULTIPLEXED HISTOLOGY | VENTANA MEDICAL SYSTEMS, INC. | 2014-09-18 | — | — | US | disclosed |
| WO-2014143155-A1 | DIGITALLY ENHANCED MICROSCOPY FOR MULTIPLEXED HISTOLOGY | VENTANA MEDICAL SYSTEMS, INC. (US) | 2014-09-18 | — | — | WO | disclosed |
| US-20130260379-A1 | SIGNALING CONJUGATES AND METHODS OF USE | VENTANA MEDICAL SYSTEMS, INC. (US) | 2013-10-03 | — | — | US | disclosed |
| US-20130260379-A1 | SIGNALING CONJUGATES AND METHODS OF USE | VENTANA MEDICAL SYSTEMS, INC. (US) | 2013-10-03 | — | — | US | disclosed |
| EP-2588443-A2 | HAPTEN CONJUGATES FOR TARGET DETECTION | Ventana Medical Systems, Inc. (US) | 2013-05-08 | — | — | EP | disclosed |
| US-20130109019-A1 | HAPTEN CONJUGATES FOR TARGET DETECTION | VENTANA MEDICAL SYSTEMS, INC. | 2013-05-02 | — | — | US | disclosed |
| WO-2012003476-A2 | HAPTEN CONJUGATES FOR TARGET DETECTION | VENTANA MEDICAL SYSTEMS, INC. (US) | 2012-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130109019-A1 | HAPTEN CONJUGATES FOR TARGET DETECTION | TYR, TH, TYRO3 | GFER 1832/4885ADORA2A 2326/4885ADORA1 2751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.